Cover Image
市場調查報告書

遺傳基因檢驗的北美市場未來展望

North America Genetic Testing Market Outlook to 2024

出版商 GlobalData 商品編碼 346083
出版日期 內容資訊 英文 381 Pages
訂單完成後即時交付
價格
Back to Top
遺傳基因檢驗的北美市場未來展望 North America Genetic Testing Market Outlook to 2024
出版日期: 2017年12月01日 內容資訊: 英文 381 Pages
簡介

本報告提供北美各國 (美國、加拿大、墨西哥) 的遺傳基因檢驗市場相關分析、相關產品與服務的市場規模 (以金額為準:後天性遺傳基因/染色體變化的檢驗、先天性的遺傳基因/染色體變化的檢驗、其他檢驗等) 的實際成果值和預測值、各流通管道、各主要企業的市場佔有率、主要企業簡介、有未來潛力的開發中產品的資訊、最新的資本交易、企業發展資訊等調查評估。

第1章 目錄

第2章 簡介

  • 本報告概要
  • 遺傳基因檢驗市場明細
  • 定義與分析範圍

第3章 北美的遺傳基因檢驗市場

  • 市場收益額 (以金額為準,總計15年份)
  • 市場收益額的各類別比較 (總計15年份)
  • 市場收益額的轉變 (以金額為準,過去8年份)
  • 市場收益額的預測 (以金額為準,今後8年份)
  • 各企業的市場收益額佔有率

第4章 加拿大的遺傳基因檢驗市場

  • 市場收益額的轉變 (以金額為準,過去8年份)
  • 市場收益額的預測 (以金額為準,今後8年份)
  • 各流通管道的市場收益額佔有率
  • 各企業的市場收益額佔有率

第5章 墨西哥的遺傳基因檢驗市場

  • 市場收益額的轉變 (以金額為準,過去8年份)
  • 市場收益額的預測 (以金額為準,今後8年份)
  • 各流通管道的市場收益額佔有率
  • 各企業的市場收益額佔有率

第6章 美國的遺傳基因檢驗市場

  • 市場收益額的轉變 (以金額為準,過去8年份)
  • 市場收益額的預測 (以金額為準,今後8年份)
  • 各流通管道的市場收益額佔有率
  • 各企業的市場收益額佔有率

第7章 主要企業概要

  • F. Hoffmann-La Roche Ltd.
  • Siemens Healthcare
  • Danaher Corporation
  • Abbott Laboratories
  • Hologic, Inc.
  • Qiagen N.V.
  • Transgenomic, Inc.
  • PerkinElmer, Inc.
  • Bio-Rad Laboratories, Inc.
  • Cepheid

第8章 遺傳基因檢驗市場開發中產品

第9章 資本交易環境

  • 產業聯盟

第10章 近幾年趨勢

  • 來自企業的發表
  • 財務報告
  • 政府、公益相關
  • 法規、規定的動向
  • 其他主要動向
  • 產品新聞
  • 研究開發 (R&D)
  • 策略、產業計畫

第11章 附錄

圖表一覽

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDMECR0746DB

GlobalData's new report, North America Genetic Testing Market Outlook to 2024, provides key market data on the North America Genetic Testing market. The report provides value, in millions of US dollars within market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size and company share data for Genetic Testing market segments - Acquired Gene or Chromosome Alterations, Inborn Gene or Chromosome Alterations and Other Genetic Tests
  • Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
  • 2017 company shares and distribution shares data for each of the market segments.
  • Global corporate-level profiles of key companies operating within the North America Genetic Testing market.
  • Key players covered include F. Hoffmann-La Roche Ltd, Abbott Laboratories and Luminex Corp.

Reasons to buy

  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what's the most preferred mode of product distribution - Identify, understand and capitalize.

Table of Contents

1 Table of Contents

1 Table of Contents 2

  • 1.1 List of Tables 3
  • 1.2 List of Figures 3

2 Introduction 4

  • 2.1 What Is This Report About? 4
  • 2.2 Genetic Testing Market Segmentation 4

3 Genetic Testing Market, North America 6

  • 3.1 Genetic Testing Market, North America, Revenue ($m), 2010-2024 6
  • 3.2 Genetic Testing Market, North America, Category Comparison by Revenue ($m), 2010-2024 8
  • 3.3 Genetic Testing Market, North America, Revenue ($m), 2010-2017 9
  • 3.4 Genetic Testing Market, North America, Revenue ($m), 2017-2024 11
  • 3.5 Genetic Testing Market, North America, Company Share by Revenue ($m), 2017 13

4 Genetic Testing Market, Canada 15

  • 4.1 Genetic Testing Market, Canada, Revenue ($m), 2010-2017 15
  • 4.2 Genetic Testing Market, Canada, Revenue ($m), 2017-2024 17
  • 4.3 Genetic Testing Market, Canada, Distribution Share by Revenue ($m), 2017 19
  • 4.4 Genetic Testing Market, Canada, Company Share by Revenue ($m), 2017 20

5 Genetic Testing Market, Mexico 22

  • 5.1 Genetic Testing Market, Mexico, Revenue ($m), 2010-2017 22
  • 5.2 Genetic Testing Market, Mexico, Revenue ($m), 2017-2024 24
  • 5.3 Genetic Testing Market, Mexico, Distribution Share by Revenue ($m), 2017 26
  • 5.4 Genetic Testing Market, Mexico, Company Share by Revenue ($m), 2017 27

6 Genetic Testing Market, United States 29

  • 6.1 Genetic Testing Market, United States, Revenue ($m), 2010-2017 29
  • 6.2 Genetic Testing Market, United States, Revenue ($m), 2017-2024 31
  • 6.3 Genetic Testing Market, United States, Distribution Share by Revenue ($m), 2017 33
  • 6.4 Genetic Testing Market, United States, Company Share by Revenue ($m), 2017 34

7 Overview of Key Companies in North America Genetic Testing Market 36

  • 7.1 F. Hoffmann-La Roche Ltd 36
  • 7.2 Abbott Laboratories 36
  • 7.3 PerkinElmer Inc 36
  • 7.4 Hologic Inc 37
  • 7.5 Qiagen NV 37
  • 7.6 Myriad Genetics Inc 37
  • 7.7 Luminex Corp 37

8 Genetic Testing Market Pipeline Products 38

9 Recent Developments 42

  • 9.1 Corporate Communications 42
  • 9.2 Financial Announcements 102
  • 9.3 Government and Public Interest 241
  • 9.4 Legal And Regulatory 244
  • 9.5 Other Significant Developments 252
  • 9.6 Product News 281
  • 9.7 Strategy And Business Planning 356

10 Appendix 363

  • 10.1 Research Methodology 364
  • 10.2 GlobalData Consulting 368
  • 10.3 Contact Us 369
  • 10.4 Disclaimer 369

List of Tables

1.1 List of Tables

  • Table 1: Genetic Testing Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 19
  • Table 2: Genetic Testing Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 20
  • Table 3: Genetic Testing Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 22
  • Table 4: Genetic Testing Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 24
  • Table 5: Genetic Testing Market, North America, Company Share by Revenue ($m), USD Constant, 2017 26
  • Table 6: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 28
  • Table 7: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 30
  • Table 8: Genetic Testing Market, Canada, Distribution Share by Revenue ($m), USD Constant, 2017 31
  • Table 9: Genetic Testing Market, Canada, Company Share by Revenue ($m), USD Constant, 2017 33
  • Table 10: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 35
  • Table 11: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 37
  • Table 12: Genetic Testing Market, Mexico, Distribution Share by Revenue ($m), USD Constant, 2017 38
  • Table 13: Genetic Testing Market, Mexico, Company Share by Revenue ($m), USD Constant, 2017 40
  • Table 14: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 42
  • Table 15: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 44
  • Table 16: Genetic Testing Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 45
  • Table 17: Genetic Testing Market, United States, Company Share by Revenue ($m), USD Constant, 2017 47
  • Table 18: Genetic Testing Market Pipeline Products 50
  • Table 19: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 378

List of Figures

1.2 List of Figures

  • Figure 1: Genetic Testing Market, Cross Country Comparison, North America, Revenue ($m), USD Constant, 2010-2024 18
  • Figure 2: Genetic Testing Market, North America, Category Comparison by Revenue ($m), USD Constant, 2010-2024 20
  • Figure 3: Genetic Testing Market, North America, Revenue ($m), Historic, USD Constant, 2010-2017 21
  • Figure 4: Genetic Testing Market, North America, Revenue ($m), Forecast, USD Constant, 2017-2024 23
  • Figure 5: Genetic Testing Market, North America, Company Share (%) 2017 25
  • Figure 6: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Historic, 2010-2017 27
  • Figure 7: Genetic Testing Market, Canada, Revenue ($m), USD Constant, Forecast, 2017-2024 29
  • Figure 8: Genetic Testing Market, Canada, Company Share (%) 2017 32
  • Figure 9: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Historic, 2010-2017 34
  • Figure 10: Genetic Testing Market, Mexico, Revenue ($m), USD Constant, Forecast, 2017-2024 36
  • Figure 11: Genetic Testing Market, Mexico, Company Share (%) 2017 39
  • Figure 12: Genetic Testing Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 41
  • Figure 13: Genetic Testing Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 43
  • Figure 14: Genetic Testing Market, United States, Company Share (%) 2017 46
Back to Top